Frequently asked questions.

Enigma Genetics LLC is an early-stage company building consent-governed infrastructure for personal genomic and health data. The platform consists of GeneVault (a user-controlled data vault), 0mnimind (an AI health companion, pronounced “OmniMind”), and a consent-governed access system.

No. Enigma Genetics LLC is independent and is not affiliated with the ENIGMA Consortium (a brain-imaging research collaboration), Enigma Genomics, or any similarly named organizations.

It is pronounced “OmniMind.” The product name is spelled with a leading zero: 0mnimind.

No. 0mnimind is an educational and organizational tool. It does not diagnose, treat, prescribe, or replace medical care, and it is not a regulated medical device. Always consult a licensed healthcare professional for medical decisions.

GeneVault is being designed so that the keys needed to decrypt user-controlled biological data are held on user-controlled hardware, not by Enigma Genetics. Specific cryptographic primitives and key-management approaches are part of the platform’s security roadmap and may evolve over time. See Security.

Compliance with HIPAA, GDPR, and SOC 2 is part of Enigma Genetics’ compliance roadmap. Enigma Genetics has not stated that it currently holds these certifications, and any specific certifications depend on independent assessment and auditing.

No. Enigma Genetics does not sell user genetic or health data. Any access to user data is gated by explicit, revocable user consent, scoped in time and purpose.

You can join the waitlist for early access, try 0mnimind, read the whitepaper, or explore the kit demo.